Tibet Rhodiola Pharmaceutical Holding Co (600211) — Financial Flexibility Index
Tibet Rhodiola Pharmaceutical Holding Co (600211) has a Financial Flexibility Index of 0.14x as of December 2025. Free cash flow of CN¥302.85 Million (operating CF CN¥297.86 Million minus capex CN¥4.98 Million) represents 0% of total liabilities (CN¥2.10 Billion). Also explore Tibet Rhodiola Pharmaceutical Holding Co annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tibet Rhodiola Pharmaceutical Holding Co Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Tibet Rhodiola Pharmaceutical Holding Co across 27 annual periods. Check Tibet Rhodiola Pharmaceutical Holding Co (600211) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Tibet Rhodiola Pharmaceutical Holding Co (1999–2025)
Year-by-year free cash flow to debt coverage for Tibet Rhodiola Pharmaceutical Holding Co. For the full company profile including market capitalisation, see 600211 company net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | CN¥1.04 Billion | CN¥1.03 Billion | CN¥2.10 Billion | ▼ -61.8% |
| 2024 | 1.30x | CN¥1.03 Billion | CN¥994.79 Million | CN¥795.23 Million | ▲ +42.7% |
| 2023 | 0.91x | CN¥1.10 Billion | CN¥1.08 Billion | CN¥1.21 Billion | ▲ +3.5% |
| 2022 | 0.88x | CN¥939.34 Million | CN¥837.38 Million | CN¥1.07 Billion | ▲ +28.5% |
| 2021 | 0.68x | CN¥792.11 Million | CN¥366.53 Million | CN¥1.16 Billion | ▼ -62.5% |
| 2020 | 1.82x | CN¥649.46 Million | CN¥428.17 Million | CN¥355.91 Million | ▲ +8.6% |
| 2019 | 1.68x | CN¥538.59 Million | CN¥489.59 Million | CN¥320.44 Million | ▲ +47.8% |
| 2018 | 1.14x | CN¥312.58 Million | CN¥289.22 Million | CN¥274.89 Million | ▼ -53.7% |
| 2017 | 2.46x | CN¥699.43 Million | CN¥91.46 Million | CN¥284.64 Million | ▲ +1443.8% |
| 2016 | 0.16x | CN¥259.85 Million | CN¥250.21 Million | CN¥1.63 Billion | ▼ -75.7% |
| 2015 | 0.66x | CN¥144.59 Million | CN¥133.93 Million | CN¥220.43 Million | ▲ +465.5% |
| 2014 | -0.18x | CN¥-113.48 Million | CN¥-141.40 Million | CN¥632.26 Million | ▼ -142.3% |
| 2013 | 0.42x | CN¥313.34 Million | CN¥279.22 Million | CN¥738.26 Million | ▲ +221.9% |
| 2012 | 0.13x | CN¥60.62 Million | CN¥56.20 Million | CN¥459.72 Million | ▲ +296.4% |
| 2011 | 0.03x | CN¥14.40 Million | CN¥12.09 Million | CN¥432.93 Million | ▲ +205.5% |
| 2010 | 0.01x | CN¥4.48 Million | CN¥1.90 Million | CN¥411.28 Million | ▼ -77.6% |
| 2009 | 0.05x | CN¥21.59 Million | CN¥17.88 Million | CN¥443.70 Million | ▲ +2.0% |
| 2008 | 0.05x | CN¥26.26 Million | CN¥21.46 Million | CN¥550.51 Million | ▲ +2997.5% |
| 2007 | 0.00x | CN¥-918.00K | CN¥-18.30 Million | CN¥557.68 Million | ▼ -101.6% |
| 2006 | 0.11x | CN¥49.53 Million | CN¥33.63 Million | CN¥470.56 Million | ▲ +73.1% |
| 2005 | 0.06x | CN¥25.99 Million | CN¥18.92 Million | CN¥427.37 Million | ▼ -53.1% |
| 2004 | 0.13x | CN¥44.35 Million | CN¥26.90 Million | CN¥341.74 Million | ▼ -38.9% |
| 2003 | 0.21x | CN¥70.08 Million | CN¥47.20 Million | CN¥329.82 Million | ▼ -50.5% |
| 2002 | 0.43x | CN¥135.00 Million | CN¥32.85 Million | CN¥314.23 Million | ▼ -8.9% |
| 2001 | 0.47x | CN¥95.19 Million | CN¥15.47 Million | CN¥201.82 Million | ▼ -57.2% |
| 2000 | 1.10x | CN¥139.00 Million | CN¥20.55 Million | CN¥126.01 Million | ▼ -21.3% |
| 1999 | 1.40x | CN¥65.50 Million | CN¥2.25 Million | CN¥46.73 Million | — |